CAN A CURE BE ACHIEVED WITH TAXANE-BASED CHEMOTHERAPY IN PATIENTS WITH PRIMARY MEDIASTINAL NON-SEMINOMATOUS GERM CELL TUMORS (NGCT) AND PROGRESSION OR RELAPSE DESPITE FIRST-LINE CHEMOTHERAPY?

被引：0
|
作者：
Miskovska, V. [1 ]
Levy, A. [1 ]
Sauvin, L. Albiges [1 ]
Massard, C. [1 ]
Gross-Goupil, M. [1 ]
Bossi, A. [1 ]
Fizazi, K. [1 ]
机构：
[1] Inst Gustave Roussy, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：204 / 205
页数：2
相关论文
共 50 条
  • [41] Is it time to discontinue using high-dose chemotherapy for salvage of patients with advanced germ-cell tumors failing first-line platinum chemotherapy?
    Oyan, B
    Koc, Y
    ANNALS OF ONCOLOGY, 2006, 17 (02) : 349 - 350
  • [42] The Effect of Surgical Resection and First-Line Chemotherapy on Treatment Outcome of Pediatric Malignant Mediastinal Germ Cell Tumors: Taiwan Pediatric Oncology Group Report
    Huang, T. -H.
    Hung, G. Y.
    Lin, K. -H.
    Weng, D. -F.
    Wang, F. M.
    Lee, C. -Y.
    Lin, D. T.
    Chen, B. W.
    Wu, K. -H.
    Chen, J. -S.
    Jou, S. -T.
    Liu, H. -C.
    Hou, J. -Y.
    Yang, Y. -L.
    Chen, R. -L.
    Hsiao, C. -C.
    Chen, S. -H.
    Yen, H. -J.
    Yang, C. -P.
    Chang, T. K.
    Lu, M. -Y.
    Cheng, C. -N.
    Sheen, J. -M.
    Chiou, S. -S.
    Lin, P. -C.
    Chang, H. -H.
    Liao, Y. -M.
    Yeh, T. -C.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S11 - S12
  • [43] 2 cycles cisplatin-based chemotherapy for low volume retroperitoneal stage II non-seminomatous germ cell tumors -: Oncologic efficacy and long term results
    Steiner, H
    Höltl, L
    Berger, AP
    Bartsch, G
    Hobisch, A
    JOURNAL OF UROLOGY, 2003, 169 (04): : 240 - 240
  • [44] A phase II trial of paclitaxel, ifosfamid and cisplatin in patients with poor-prognosis disseminated non-seminomatous germ cell tumors with unfavorable serum tumor marker decline after first cycle of chemotherapy
    Mego, M.
    Svetlovska, D.
    Rejlekova, K.
    Miskovska, V.
    De Angelis, V.
    Kalavska, K.
    Obertova, J.
    Palacka, P.
    Sycova-Mila, Z.
    Chovanec, M.
    Mardiak, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S600 - S600
  • [45] First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients
    Smith, I. E.
    Pierga, J. -Y.
    Biganzoli, L.
    Cortes-Funes, H.
    Thomssen, C.
    Pivot, X.
    Fabi, A.
    Xu, B.
    Stroyakovskiy, D.
    Franke, F. A.
    Kaufman, B.
    Mainwaring, P.
    Pienkowski, T.
    De Valk, B.
    Kwong, A.
    Gonzalez-Trujillo, J. L.
    Koza, I.
    Petrakova, K.
    Pereira, D.
    Pritchard, K. I.
    ANNALS OF ONCOLOGY, 2011, 22 (03) : 595 - 602
  • [46] First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors
    Kumano, Masafumi
    Miyake, Hideaki
    Hara, Isao
    Furukawa, Junya
    Takenaka, Atsushi
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (04) : 336 - 338
  • [47] Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: Evaluation of a prognostic score for survival after high-dose chemotherapy
    Sammler, C.
    Beyer, J.
    Bokemeyer, C.
    Hartmann, J. T.
    Rick, O.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (02) : 237 - 243
  • [48] RISK OF RESIDUAL TERATOMA AFTER COMPLETE RESPONSE FOLLOWING FIRST-LINE CHEMOTHERAPY IN MEN WITH METASTATIC NON-SEMINOMATOUS GERM CELL TUMOR AND IGCCCG INTERMEDIATE/POOR PROGNOSIS: A MULTI-INSTITUTIONAL RETROSPECTIVE COHORT STUDY
    Antonelli, Luca
    Ardizzone, Davide
    Ravi, Praful
    Sweeney, Christopher
    Bagrodia, Aditya
    Mego, Michal
    Daneshmand, Sia
    Giannatempo, Patrizia
    Nazzani, Sebastiano
    Franza, Andrea
    Heidenreich, Axel
    Paffenholz, Pia
    Saoud, Ragheed
    Eggener, Scott
    Ho, Matthew
    Oswald, Nathaniel
    Tryakin, Alexey
    Naoun, Natacha
    Javaud, Christophe
    Douglawi, Antoin
    Cary, Clint
    King, Jennifer M.
    Adra, Nabil
    Fankhauser, Christian D.
    JOURNAL OF UROLOGY, 2023, 209 : E450 - E450
  • [49] Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study
    Antonelli, Luca
    Ardizzone, Davide
    Ravi, Praful
    Bagrodia, Aditya
    Mego, Michal
    Daneshmand, Siamak
    Nicolai, Nicola
    Nazzani, Sebastiano
    Giannatempo, Patrizia
    Franza, Andrea
    Heidenreich, Axel
    Paffenholz, Pia
    Saoud, Ragheed
    Eggener, Scott
    Ho, Matthew
    Oswald, Nathaniel
    Olson, Kathleen
    Tryakin, Alexey
    Fedyanin, Mikhail
    Naoun, Natacha
    Javaud, Christophe
    Fizazi, Karim
    King, Jennifer M.
    Adra, Nabil
    Douglawi, Antoin
    Cary, Clint
    Sweeney, Christopher
    Fankhauser, Christian D.
    EUROPEAN JOURNAL OF CANCER, 2023, 182 : 144 - 154
  • [50] Economic evaluation of taxane-based first-line chemotherapy in the treatment of patients with metastatic breast cancer in Greece: an analysis alongside a multicenter, randomized phase III clinical trial
    Maniadakis, N.
    Dafni, U.
    Fragoulakis, V.
    Grimani, I.
    Galani, E.
    Fragkoulidi, A.
    Fountzilas, G.
    ANNALS OF ONCOLOGY, 2009, 20 (02) : 278 - 285
12345